Skip to main content

Advertisement

Table 2 Clinicopathological characteristics of all SCCHN patients

From: Hsp70 - a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neck

Patient # Tumor location Stadium Grading Therapy
T N M Surgery RTx dose (Gy)
1 Oral cavity 2 2 cd 0 2 + 0
2 Larynx 4 2b 0 3 + 64
3 Oral Cavity 1 0 0 2 + 60
4 Oro/Hypopharynx 4 2a 0 2 + 64
5 Oropharynx 3 2 0 2 - 70
6 Oropharynx 1 2b 0 3 + 64
7 Oral Cavity 1 2a 0 2 + 64
8 Oro/Hypopharynx 1 0 0 2 + 64
9 Oral Cavity 1 0 0 2 + 64
10 Oral Cavity 1 0 0 3 + 0
11 Oropharynx 2 2a 0 2 + 0
12 Larynx 2 2b 0 3 + 0
13 Oropharynx 4 0 0 2 + 64
14 Oropharynx 2 0 0 3 + 64
15 Larynx 3 0 0 3 + 64
16 Larynx 4 1 0 3 + 0
17 Oropharynx 2 2b 0 3 + 0
18 Oropharynx 2 1 0 2 + 64
19 Larynx 2 1 0 2 + 64
20 Sinus 2 0 0 3 + 60
21 Larynx 4 0 0 3 + 0